Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder

Lignende værker

• Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
  af: Mak, Raymond H., et al.
  Udgivet: (2014)
• Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
  af: Hafeez, S, et al.
  Udgivet: (2015)
• Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
  af: Hafeez, S, et al.
  Udgivet: (2016)
• Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
  af: Mitin, Timur, et al.
  Udgivet: (2013)
• Bladder preservation versus radical cystectomy in transitional cell carcinoma and squamous cell carcinoma muscle invasive bladder cancer
  af: Mohamed, Dalia O., et al.
  Udgivet: (2021)